Recruiting PHASE2 INTERVENTIONAL 2-arm NCT06044675

MDMA-Assisted CBCT for PTSD vs CBCT RCT

A Randomized Trial of MDMA-Assisted Cognitive-Behavioural Conjoint Therapy (CBCT) Versus CBCT in Dyads in Which One Member Has Posttraumatic Stress Disorder (PTSD)

Sponsor: Remedy

Conditions Post Traumatic Stress Disorder

Interventions MDMA assisted psychotherapy Psychotherapy

Updated 5 times since 2023 Last updated: Nov 22, 2024 Started: Nov 15, 2024 Primary completion: Dec 31, 2026 Completion: Dec 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06044675, this PHASE2 trial focuses on Post Traumatic Stress Disorder and remains actively recruiting participants. Sponsored by Remedy, it has been updated 5 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Dec 2024 — Present [monthly]

Recruiting PHASE2
Sep 2024 — Dec 2024 [monthly]

Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE2
May 2024 — Jul 2024 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
Oct 2023 — May 2024 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Remedy
Remedy Institute

Data source: Remedy

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toronto, Canada